Nektar Therapeutics (MEX:NKTR)
MXN 51.11 0 (0%) Market Cap: 4.03 Bil Enterprise Value: 1.25 Bil PE Ratio: 0 PB Ratio: 4.45 GF Score: 59/100

Nektar Therapeutics Annual Shareholders Meeting Transcript

Jun 10, 2021 / 09:00PM GMT
Release Date Price: MXN465
Mark A. Wilson
Nektar Therapeutics - Senior VP, General Counsel & Secretary

I would like to welcome everyone to Nektar Therapeutics' 2021 Annual Meeting of Stockholders. My name is Mark Wilson, Senior Vice President, General Counsel and Secretary at Nektar.

It is my pleasure to host the 2021 Annual Meeting. I will serve as Chairman and Secretary of the meeting. We are excited to be hosting this virtual meeting, which allows our stockholders to safely participate in our annual meeting. As in past years, we will conduct the business portion of our meeting first and answer questions at the end of the meeting.

Before we begin, I would like to introduce the members of our Board of Directors who are with us today: Rob Chess, the Chairman of the Board; Jeff Ajer; Myriam J. Curet; Karin Eastham; Scott Greer; Howard Robin, who is also our President and CEO; and Roy Whitfield.

Also in attendance today are certain members of Nektar's executive team. Kevin Brodbeck, Senior Vice President of Manufacturing; Gil Labrucherie, Senior Vice President, Chief Operating Officer and Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot